
Metoprolol Succinate (50mg) + Telmisartan (40mg)
Active composition
+1 more active ingredient
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
The Nizatel Beta 50 Tablet ER is a combined medication containing Telmisartan 40mg and Metoprolol Succinate 50mg. This extended-release formulation is designed for the management of hypertension (high blood pressure). Telmisartan, an angiotensin II receptor antagonist, works by blocking the action of angiotensin II, thereby reducing blood pressure. Metoprolol Succinate, a beta-blocker, helps to slow the heart rate and reduce its output of blood, also contributing to lowering blood pressure. The combined therapy aims to provide optimal blood pressure control with a single medication, enhancing patient compliance and convenience. As with any medication, potential side effects may occur, and it is essential to follow the prescribed dosage and any accompanying instructions provided by a healthcare professional.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nizatel Beta 50 Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Nizatel Beta 50 Tablet ER is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Nizatel Beta 50 Tablet ER is safe to use in patients with kidney disease. No dose adjustment of Nizatel Beta 50 Tablet ER is recommended.
Exercise Caution
Nizatel Beta 50 Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nizatel Beta 50 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Nizatel Beta 50 Tablet ER may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Nizatel Beta 50 Tablet ER

Telmisartan (40mg) + Metoprolol Succinate (50mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
The Nizatel Beta 50 Tablet ER is a combined medication containing Telmisartan 40mg and Metoprolol Succinate 50mg. This extended-release formulation is designed for the management of hypertension (high blood pressure). Telmisartan, an angiotensin II receptor antagonist, works by blocking the action of angiotensin II, thereby reducing blood pressure. Metoprolol Succinate, a beta-blocker, helps to slow the heart rate and reduce its output of blood, also contributing to lowering blood pressure. The combined therapy aims to provide optimal blood pressure control with a single medication, enhancing patient compliance and convenience. As with any medication, potential side effects may occur, and it is essential to follow the prescribed dosage and any accompanying instructions provided by a healthcare professional.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nizatel Beta 50 Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Nizatel Beta 50 Tablet ER is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Nizatel Beta 50 Tablet ER is safe to use in patients with kidney disease. No dose adjustment of Nizatel Beta 50 Tablet ER is recommended.
Exercise Caution
Nizatel Beta 50 Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nizatel Beta 50 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Nizatel Beta 50 Tablet ER may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Nizatel Beta 50 Tablet ER















